Company Filing History:
Years Active: 2011-2017
Title: Brijesh K Srivastava: Innovator in Pharmaceutical Chemistry
Introduction
Brijesh K Srivastava is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents to his name, he continues to push the boundaries of innovation in his field.
Latest Patents
One of his latest patents is titled "Substituted phthalazin-1 (2H)-one derivatives as selective inhibitors of poly (ADP-ribose) polymerase-1." This invention relates to novel compounds of general formula (I), including their stereoisomers, regioisomers, and tautomeric forms. It also covers the process of preparing these compounds and their pharmaceutically acceptable salts and compositions.
Another significant patent is "Tricyclic pyrazole derivatives as cannabinoid receptor modulators." This invention also focuses on novel compounds of general formula (I) and includes their regioisomers and tautomeric forms. The patent outlines the process of preparing these compounds and their pharmaceutical applications.
Career Highlights
Brijesh K Srivastava is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work at the company has allowed him to contribute to various innovative projects aimed at improving healthcare solutions.
Collaborations
Throughout his career, Brijesh has collaborated with esteemed colleagues, including Ranjit C Desai and Pankaj Ramanbhai Patel. These collaborations have further enriched his research and development efforts in the pharmaceutical domain.
Conclusion
Brijesh K Srivastava stands out as a dedicated inventor in pharmaceutical chemistry, with a focus on developing innovative compounds for therapeutic use. His contributions through patents and collaborations highlight his commitment to advancing healthcare solutions.